Related references
Note: Only part of the references are listed.Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses
Varun Warrier et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis
Rebecca E. H. Whiting et al.
EXPERIMENTAL EYE RESEARCH (2013)
Progressive conduction defects and cardiac death in late infantile neuronal ceroid lipofuscinosis
Shinobu Fukumura et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2012)
Enzyme replacement therapy for lysosomal storage diseases
Robin H. Lachmann
CURRENT OPINION IN PEDIATRICS (2011)
A reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis
D. N. Sanders et al.
GENES BRAIN AND BEHAVIOR (2011)
Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis
Brian R. Vuillemenot et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Therapy for the mucopolysaccharidoses
Vassili Valayannopoulos et al.
RHEUMATOLOGY (2011)
Morphologic Changes Associated with Intrathecal Catheters for Direct Delivery to the Central Nervous System in Preclinical Studies
Mark T. Butt
TOXICOLOGIC PATHOLOGY (2011)
New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases
Jeffrey H. Grubb et al.
REJUVENATION RESEARCH (2010)
The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease
Chantal F. Morell et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
Michael Chang et al.
MOLECULAR THERAPY (2008)
Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis
Martin L. Katz et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis
Tomoyuki Awano et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis
MA Passini et al.
JOURNAL OF NEUROSCIENCE (2006)
Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis
L Lin et al.
BIOCHEMICAL JOURNAL (2001)
Share Paper
